Mark Dybul is Chief Executive Officer of Enochian Biosciences Inc. Currently has a direct ownership of 66,196 shares of ENOB, which is worth approximately $304,501. The most recent transaction as insider was on Dec 14, 2020, when has been sold 180 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.2K
0% 3M change
0% 12M change
Total Value Held $304,501

Mark Dybul Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2020
BUY
Other acquisition or disposition
-
180 Added 0.27%
66,196 Common Stock
MD

Mark Dybul

Chief Executive Officer
Chestertown, MD

Track Institutional and Insider Activities on ENOB

Follow Enochian Biosciences Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENOB shares.

Notify only if

Insider Trading

Get notified when an Enochian Biosciences Inc insider buys or sells ENOB shares.

Notify only if

News

Receive news related to Enochian Biosciences Inc

Track Activities on ENOB